TriangleNCT02933320 · MORE INFO
Limitations, agreements, and source contact
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- certain Agreement
- pi Sponsor Employee
- false
- restrictive Agreement
- false
- limitations And Caveats
- description
- The trial was terminated early by the Sponsor based on a strategic decision and not a safety related decision. At the time of trial termination, 14 patients had received BI-1206. No patients received rituximab. As a result of the early termination Part B of the trial did not open.
- point Of Contact
- regulatory@cancer.org.uk
- organization
- Cancer Research UK Centre for Drug Development
- phone
- +44 203 4696878
- title
- Regulatory Affairs Manager
Complete source fields
- certain Agreement
- pi Sponsor Employee
- false
- restrictive Agreement
- false
- limitations And Caveats
- description
- The trial was terminated early by the Sponsor based on a strategic decision and not a safety related decision. At the time of trial termination, 14 patients had received BI-1206. No patients received rituximab. As a result of the early termination Part B of the trial did not open.
- point Of Contact
- regulatory@cancer.org.uk
- organization
- Cancer Research UK Centre for Drug Development
- phone
- +44 203 4696878
- title
- Regulatory Affairs Manager
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice